France's IMPLANET 2025 revenue rises

Implanet SA

13/01/2026 17:11

Overview

France-based orthopedic implant maker's 2025 revenue rose 33% to €12.5 mln

U.S. sales increased 49%, driven by medical equipment distribution

First deliveries of JAZZ to China contributed to 55% growth in rest of world

Outlook

IMPLANET aims to accelerate U.S. sales following FDA clearance of JSS range

Result Drivers

U.S. SALES GROWTH - Co's U.S. sales increased 49% in 2025, driven by the expansion of medical equipment distribution

CHINA DELIVERIES - First deliveries of JAZZ to China contributed to 55% growth in rest of world

FRENCH MARKET EXPANSION - Growth in implant sales driven by new accounts in France and new export markets

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
FY Revenue
EUR 12.50 mln


Press Release: ID:nBwbZshvYa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)